The Raptiva Pregnancy Registry: An observational study of the use and safety of Raptiva (efalizumab) during pregnancy

Trial Profile

The Raptiva Pregnancy Registry: An observational study of the use and safety of Raptiva (efalizumab) during pregnancy

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Nov 2014

At a glance

  • Drugs Efalizumab (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions
  • Acronyms FOLLOW
  • Sponsors Genentech
  • Most Recent Events

    • 13 Feb 2010 Actual end date (Sep 2009) added as reported by ClinicalTrials.gov.
    • 13 Feb 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Sep 2009 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top